Agenda The role of MHRA, Hospitals and the Manufacturer

Slides:



Advertisements
Similar presentations
Managing the Health and Safety of Contractors
Advertisements

And the provisions of….. the Medical Devices Regulations Medical Devices Agency.
Medical Devices The current legislative and administrative structure.
The regulation of medical devices in Australia. Overview Comparing medicines and medical devices What is a medical device? Statistics on patients requiring.
SAFE-ITSM STANDARDS.
Improving outcomes for older people: Monitoring and regulating standards Ann Close 8 th June 2011.
ISO in Histopathology Louise O’Callaghan MSc FAMLS
© Safeguarding public health Adverse incident reporting now and the future, roles and responsibilities Mark Grumbridge.
How a Health and Safety Professional can be an asset to your operation.
Creating a Culture of Safety: Challenges in Ophthalmology James P. Bagian, MD, PE Director, Center for Health Engineering University of Michigan Founding.
Council Directive 2010/32/EU Implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by.
Susan Best, NRL, Australia WHO post-market surveillance for In Vitro Diagnostic Devices (IVD)
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.
© Safeguarding public health BIOABSORBABLE STENTS: REGULATORY ISSUES DR SUSANNE LUDGATE Clinical Director Medicines and Healthcare products Regulatory.
Implementation - Medical Devices. Overview Act on Medical Devices – background and overview. Surveillance - Competent authority. Directive 93/42. Directive.
S4: Market Surveillance Physikalisch-Technische Bundesanstalt Session 4: Market surveillance Peter Ulbig, Harry Stolz Belgrade, 31 October.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
DE LA SALLE HIGH SCHOOL 1 Year 13 BTEC Sport Unit 3: Assessing Risk in Sport Knowing how to maintain the safety of participants and colleagues in a sports.
CE marking Catriona Blake Team Manager, Imaging, acute and community care.
The Introduction of a Specialist Paediatric Vascular Access team Sara Melville, Lead Nurse Vascular Access, Alder Hey.
1. Basic terms 2. Council of Europe recommendations for patient safety
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
by Joint Commission International (JCI)
Janine Webster (Medical Device Training Officer)
NORTH AMERICAN SAFETY CHECKLIST – SB 158. Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc. Presented By:
Health and Safety Executive Health and Safety Executive Regulation of distribution and farm level uses Paul Adamson & Helena Cooke.
Module 3. Session DCST Clinical governance
The Policy Company Limited © Control of Infection.
Raising and escalating concerns: Guidance for nurses and midwives.
Commissioner Feedback for SLAM CQC Inspection in September 2015 Engagement with Member Practices 1.
How to use the EFQM Excellence Model to empower patients and staff create a latex- safe environment Karen Cunningham Health & Safety Manager Musgrave Park.
Serious Untoward Incidents -The role of the GMC - Dr Colin Pollock GMC Employer Liaison Adviser (Y&H) Y&H Deanery School of Surgery Conference 26 th April.
Aligning professional and systems regulation: Can the whole be greater than the sum of its parts? Jon Billings Director of Strategy, Nursing and Midwifery.
Administration Safety PHCL 492. Standards for Medicines Management  ‘When required to administer medication a practitioner is accountable for his or.
1 MARKET SURVEILLANCE IN THE EUROPEAN UNION A coordinate approach for metrology Lucia Palmegiani Policy Officer, DG ENTR I.5 WELMEC, WG 5, Malta, 23 October.
11 The impact of falls risk management on compliance with essential standards Sue Burn, Compliance Manager.
Directorate General for Enterprise and Industry European Commission The New Legislative Framework - Market Surveillance UNECE “MARS” Group meeting Bratislava,
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
Remodelling COMAH \\ Changing the way we regulate major hazards Sarah Shore Programme Manager the Competent Authority.
REVALIDATION: THE BASICS November GMC or UKPHR? Revalidation is not an FPH process It is a process of the GMC and UKPHR for people who want to retain.
Office of Human Research Protection Georgia Health Sciences University.

Quality and Patient Safety Presented by Jane Foster-Taylor, Chief Nurse Annual General Meeting 2015.
Safeguarding the public: Through ensuring Fitness to Practise.
Final HIPAA Rule Special Training What you need to know to remain compliant with the new regulations.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
Laboratory equipment Dr. W. Huisman Cairo, November 21th 2012.
Care Quality Commission (CQC) Registration. Background The Care Quality Commission (CQC) is the health and social care regulator for England. From 1 April.
CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
Quality Issues in Health and Social Care Maria O’Connell – Acting Team Manager, Social Care Direct & Jane Wilson – Designated Nurse for Safeguarding Adults,
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.
Data access for public health, the current position, next steps and implications of Caldicott 1 Presented by Andy Sutherland.
Briefing on MHRA routine inspection of non-commercial clinical trials
The Quality Surveillance Team / Programme
Governing Body QAPI 2013 Update for ASC
The Working Group on Medical Measurements The 23rd Forum Meeting
Accountability and Delegation Medicines Management
An Integrated Risk Management & Safety Program: IRMSP
FDA Guidance for Industry and FDA Staff Summary of Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”) Effective: December.
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Controlling Measuring Quality of Patient Care
Combination products The paradigm shift
Commissioner Feedback for SLAM CQC Inspection in September 2015
Improving patient safety and care: Evidence from inspections
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
Insulin safety – shared learning
Presentation transcript:

Agenda The role of MHRA, Hospitals and the Manufacturer Incident Reporting Signal Detection Medical Device Regulation Managing Medical Devices Devices in Diabetes Bed rails

The role of MHRA, Hospitals and the Manufacturer in adverse incident reporting . Mark Grumbridge – Clinical Nursing Advisor, Medical Devices NAMDET, MHRA roadshow Bridgend July 2014

Content Who we are and what we do ! Roles & responsibilities Facts and figures Causes of adverse events Why should I report ? What to report Ways of reporting What happens to my report Summary

Health and Care system (April 2013)

MHRA - Who we are and what we do The MHRA is the competent authority (CA) for the UK. On behalf of the Secretary of State for Health, we administer and ensure compliance with medical device legislation in England, Northern Ireland, Scotland and Wales.

The MHRA meets its functions by: Investigating allegations received about possible non-compliance with the regulations Operating a proactive inspection programme where manufacturers are randomly selected for inspection by MHRA's own staff. Designating UK notified bodies and audits them. Investigates post-market surveillance reports received from medical device manufacturers.

MHRA in the spotlight – 2012/2013 PIP Breast Implants Metal hip implants

The Media

EU Regulatory System Notified Body Competent Authority investigation action accredit audit compliance ERs safety, performance Notified Body quality systems design dossier clinical data (literature, C/I) Competent Authority post market surveillance serious adverse events European market

Roles and responsibilities Manufacturer – to undertake post market surveillance , report issues with their products to the user and the regulator and to undertake corrective actions where necessary. To be vigilant. Hospitals – to report incidents in a timely manner, action FSN and MDA, to provide feedback to the reporter.

Once a device is on the market…. Post market surveillance Vigilance Safeguard action

Why should I report ? Professional accountability - NMC Code of Conduct - Manage risk;32. “You must act without delay if you believe that you, a colleague or anyone else may be putting someone at risk” Trust Policy

Causes of adverse events Inadequate training Local modification Too complex Not monitored Incorrect device Incorrect use Instructions not followed

What to report Device failures prior to use Device failures in use Devices causing harm to patients General safety concerns about a device Instructions not clear

Ways of reporting Follow local Trust policy for incident reporting On line reporting direct to MHRA Direct report to manufacturer SMTL Combination of all the above

SMTL Devices syringes and needles dressings, bandages, compression hosiery/stockings, gloves - surgical and examination, anaesthetic tubing and airways, urinary catheters, urine drainage systems, IV cannulae and catheters, disposable/reusable non-electrical surgical instruments, (tonsil snares, gags, forceps), IV administration sets, face masks, nebulisers, tubing (bubble, oxygen), electrodes, blood collection equipment (e.g., vacuum collection tubes), sharps containers, chemical and biological indicators used in sterilisation processes, surgical gowns and drapes. stethoscopes sutures vaginal speculums

Online reporting

Online reporting

Online reporting

What happens to my report ? Pre Triage - responsible officers review all reported incidents on a daily basis and provide a preliminary grading Triage - A daily meeting of team managers and the clinical team to review and make a final decision on grading.

What happens to my report ? Trending & Surveillance - Not all incidents need active investigation. Monitored - Manufacturers will investigate and provide a final report. Specialist investigation - ALL reports from members of the public. May conclude with a MDA

Why should I report ? You have a duty of care You may prevent serious harm to others You may be the first to identify a significant device problem of national significance

83 Medical Device alerts issued in 2012 Two weeks to publish from a decision being taken to issue a MDA

Ongoing projects to improve incident reporting

Summary Incident reporting is a fundamental part of patient care Document incidents in a timely manner It is essential reporters get feedback Direct reporting ensures a quicker response Do not overlook your own internal systems If in doubt report it!

Thank you Any Questions?